These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 35775617)

  • 1. Carrier screening for Krabbe disease in an isolated inbred community.
    Ezer S; Zuckerman S; Segel R; Zlotogora J
    Am J Med Genet A; 2022 Sep; 188(9):2555-2559. PubMed ID: 35775617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic screening for Krabbe disease: learning from the past and looking to the future.
    Macarov M; Zlotogora J; Meiner V; Khatib Z; Sury V; Mengistu G; Bargal R; Shmueli E; Meidan B; Zeigler M
    Am J Med Genet A; 2011 Mar; 155A(3):574-6. PubMed ID: 21344630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes of children with abnormal newborn screening results for Krabbe disease in New York State.
    Wasserstein MP; Andriola M; Arnold G; Aron A; Duffner P; Erbe RW; Escolar ML; Estrella L; Galvin-Parton P; Iglesias A; Kay DM; Kronn DF; Kurtzberg J; Kwon JM; Langan TJ; Levy PA; Naidich TP; Orsini JJ; Pellegrino JE; Provenzale JM; Wenger DA; Caggana M
    Genet Med; 2016 Dec; 18(12):1235-1243. PubMed ID: 27171547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for Krabbe disease: The first 2 years' experience.
    Pannuzzo G; Graziano ACE; Avola R; Drago F; Cardile V
    Acta Neurol Scand; 2019 Nov; 140(5):359-365. PubMed ID: 31350907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two different mutations are responsible for Krabbe disease in the Druze and Moslem Arab populations in Israel.
    Rafi MA; Luzi P; Zlotogora J; Wenger DA
    Hum Genet; 1996 Mar; 97(3):304-8. PubMed ID: 8786069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consensus guidelines for newborn screening, diagnosis and treatment of infantile Krabbe disease.
    Kwon JM; Matern D; Kurtzberg J; Wrabetz L; Gelb MH; Wenger DA; Ficicioglu C; Waldman AT; Burton BK; Hopkins PV; Orsini JJ
    Orphanet J Rare Dis; 2018 Feb; 13(1):30. PubMed ID: 29391017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and molecular findings in 6 Turkish cases with Krabbe disease.
    Aslanger AD; Şengenç E; Kölemen AB; Demiral E; Alkan A; İşcan A; Yeşil G
    Turk J Pediatr; 2022; 64(1):69-78. PubMed ID: 35286032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospitalization Burden and Incidence of Krabbe Disease.
    Ghabash G; Wilkes J; Barney BJ; Bonkowsky JL
    J Child Neurol; 2022 Jan; 37(1):12-19. PubMed ID: 34670440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Krabbe disease in Israel.
    Zlotogora J; Levy-Lahad E; Legum C; Iancu TC; Zeigler M; Bach G
    Isr J Med Sci; 1991 Apr; 27(4):196-8. PubMed ID: 2010272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Krabbe disease: increased incidence in a highly inbred community.
    Zlotogora J; Regev R; Zeigler M; Iancu TC; Bach G
    Am J Med Genet; 1985 Aug; 21(4):765-70. PubMed ID: 4025402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of metachromatic leukodystrophy, Krabbe disease, and Farber disease after uptake of fatty acid-labeled cerebroside sulfate into cultured skin fibroblasts.
    Kudoh T; Wenger DA
    J Clin Invest; 1982 Jul; 70(1):89-97. PubMed ID: 6806321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular defects in Krabbe disease.
    Tatsumi N; Inui K; Sakai N; Fukushima H; Nishimoto J; Yanagihara I; Nishigaki T; Tsukamoto H; Fu L; Taniike M
    Hum Mol Genet; 1995 Oct; 4(10):1865-8. PubMed ID: 8595408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carrier screening for Gaucher disease: lessons for low-penetrance, treatable diseases.
    Zuckerman S; Lahad A; Shmueli A; Zimran A; Peleg L; Orr-Urtreger A; Levy-Lahad E; Sagi M
    JAMA; 2007 Sep; 298(11):1281-90. PubMed ID: 17878420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early infantile Krabbe disease: results of the World-Wide Krabbe Registry.
    Duffner PK; Barczykowski A; Jalal K; Yan L; Kay DM; Carter RL
    Pediatr Neurol; 2011 Sep; 45(3):141-8. PubMed ID: 21824559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethical issues with testing and treatment for Krabbe disease.
    Ehmann P; Lantos JD
    Dev Med Child Neurol; 2019 Dec; 61(12):1358-1361. PubMed ID: 31090922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal diagnosis of Krabbe disease.
    Vanier MT; Svennerholm L; Månsson JE; Håkansson G; Boué A; Lindsten J
    Clin Genet; 1981 Aug; 20(2):79-89. PubMed ID: 7307314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weighing the evidence for newborn screening for early-infantile Krabbe disease.
    Kemper AR; Knapp AA; Green NS; Comeau AM; Metterville DR; Perrin JM
    Genet Med; 2010 Sep; 12(9):539-43. PubMed ID: 20601893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of newborn screening for Krabbe disease: population study and cutoff determination.
    Orsini JJ; Morrissey MA; Slavin LN; Wojcik M; Biski C; Martin M; Keutzer J; Zhang XK; Chuang WL; Elbin C; Caggana M
    Clin Biochem; 2009 Jun; 42(9):877-84. PubMed ID: 19318021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of leukocytes in diagnosis of Krabbe disease and detection of carriers.
    Svennerholm L; Vanier MT; Häkansson G; Mänsson JE
    Clin Chim Acta; 1981 May; 112(3):333-42. PubMed ID: 7237832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Krabbe leukodystrophy in a selected population with high rate of late onset forms: longer survival linked to c.121G>A (p.Gly41Ser) mutation.
    Fiumara A; Barone R; Arena A; Filocamo M; Lissens W; Pavone L; Sorge G
    Clin Genet; 2011 Nov; 80(5):452-8. PubMed ID: 21070211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.